(Q42826894)

8 November 2017

Studies using a recombinant vaccinia virus expressing the circumsporozoite protein of Plasmodium berghei (English)

1 reference

https://api.crossref.org/works/10.1016/0166-6851(91)90167-5

21 November 2022

0 references

vaccinia virus

1 reference

3

B. Moss

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1779992

21 November 2022

author name string

V. Satchidanandam

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1779992

21 November 2022

F. Zavala

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1779992

21 November 2022

language of work or name

1 reference

1 September 1991

1 reference

full work available at URL

8 November 2017

https://api.elsevier.com/content/article/PII:0166685191901675?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/0166-6851(91)90167-5

https://api.elsevier.com/content/article/PII:0166685191901675?httpAccept=text/plain

21 November 2022

1 reference

https://api.crossref.org/works/10.1016/0166-6851(91)90167-5

Molecular and Biochemical Parasitology

21 November 2022

published in

1 reference

8 November 2017

48

1 reference

8 November 2017

89-99

1 reference

8 November 2017

1

1 reference

Preliminary studies on vaccination of rhesus monkeys with irradiated sporozoites of Plasmodium knowlesi and characterization of surface antigens of these parasites

8 November 2017

3

1 reference

https://api.crossref.org/works/10.1016/0166-6851(91)90167-5

Immunization of man against falciparum and vivax malaria by use of attenuated sporozoites

21 November 2022

4

1 reference

https://api.crossref.org/works/10.1016/0166-6851(91)90167-5

Monovalent fragments (Fab) of monoclonal antibodies to a sporozoite surface antigen (Pb44) protect mice against malarial infection

21 November 2022

6

1 reference

https://api.crossref.org/works/10.1016/0166-6851(91)90167-5

Efficacy of murine malaria sporozoite vaccines: implications for human vaccine development.

21 November 2022

7

1 reference

https://api.crossref.org/works/10.1016/0166-6851(91)90167-5

Biosynthesis of Pb44, the protective antigen of sporozoites of Plasmodium berghei

21 November 2022

9

1 reference

https://api.crossref.org/works/10.1016/0166-6851(91)90167-5

Rationale for development of a synthetic vaccine against plasmodium falciparum malaria

21 November 2022

10

1 reference

https://api.crossref.org/works/10.1016/0166-6851(91)90167-5

Synthetic peptide vaccine confers protection against murine malaria

21 November 2022

12

1 reference

https://api.crossref.org/works/10.1016/0166-6851(91)90167-5

Cloned cytotoxic T cells recognize an epitope in the circumsporozoite protein and protect against malaria.

21 November 2022

13

1 reference

https://api.crossref.org/works/10.1016/0166-6851(91)90167-5

Construction of synthetic immunogen: use of new T-helper epitope on malaria circumsporozoite protein.

21 November 2022

14

1 reference

https://api.crossref.org/works/10.1016/0166-6851(91)90167-5

Genetic control of the immune response in mice to a Plasmodium falciparum sporozoite vaccine. Widespread nonresponsiveness to single malaria T epitope in highly repetitive vaccine

21 November 2022

15

1 reference

https://api.crossref.org/works/10.1016/0166-6851(91)90167-5

The purification fo four strains of poxvirus

21 November 2022

17

1 reference

https://api.crossref.org/works/10.1016/0166-6851(91)90167-5

Further Studies on the Plasmodium berghei-Anopheles stephensi: Rodent System of Mammalian Malaria

21 November 2022

18

1 reference

https://api.crossref.org/works/10.1016/0166-6851(91)90167-5

Antibodies to Sporozoites: Their Frequent Occurrence in Individuals Living in an Area of Hyperendemic Malaria

21 November 2022

19

1 reference

https://api.crossref.org/works/10.1016/0166-6851(91)90167-5

Inhibition of development of exoerythrocytic forms of malaria parasites by gamma-interferon.

21 November 2022

20

1 reference

https://api.crossref.org/works/10.1016/0166-6851(91)90167-5

Circumsporozoite protein of Plasmodium berghei: gene cloning and identification of the immunodominant epitopes

21 November 2022

21

1 reference

https://api.crossref.org/works/10.1016/0166-6851(91)90167-5

Efficient cell surface expression of class II MHC molecules in the absence of associated invariant chain

21 November 2022

24

1 reference

https://api.crossref.org/works/10.1016/0166-6851(91)90167-5

Vaccinia virus expression vectors

21 November 2022

26

1 reference

https://api.crossref.org/works/10.1016/0166-6851(91)90167-5

Cell-mediated immune responses to influenza virus antigens expressed by vaccinia virus recombinants

21 November 2022

27

1 reference

https://api.crossref.org/works/10.1016/0166-6851(91)90167-5

Resistance to human respiratory syncytial virus (RSV) infection induced by immunization of cotton rats with a recombinant vaccinia virus expressing the RSV G glycoprotein

21 November 2022

28

1 reference

https://api.crossref.org/works/10.1016/0166-6851(91)90167-5

Protection from rabies by a vaccinia virus recombinant containing the rabies virus glycoprotein gene

21 November 2022

29

1 reference

https://api.crossref.org/works/10.1016/0166-6851(91)90167-5

T-lymphocyte priming and protection against Friend leukemia by vaccinia-retrovirus env gene recombinant

21 November 2022

30

1 reference

https://api.crossref.org/works/10.1016/0166-6851(91)90167-5

Oral Salmonella typhimurium vaccine expressing circumsporozoite protein protects against malaria.

21 November 2022

31

1 reference

https://api.crossref.org/works/10.1016/0166-6851(91)90167-5

Sporozoite vaccine induces genetically restricted T cell elimination of malaria from hepatocytes

21 November 2022

32

1 reference

https://api.crossref.org/works/10.1016/0166-6851(91)90167-5

21 November 2022

Identifiers

1 reference

8 November 2017

1 reference